Lapatinib Terminated Phase 2 Trials for Malignancies / cancer treatment / Ovarian / Relapses Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Terminated | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00888810 | Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer | |
NCT02294786 | Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer | |
NCT00447226 | Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists |